Global Opioids Market Size (2024 - 2029)

The opioids market is projected to experience growth over the forecast period, driven by an increasing prevalence of chronic pain conditions and a shift towards extended-release formulations and abuse-deterrent formulations. The market's expansion is supported by the standard practice of using opioids for chronic pain management and their critical role in post-operative care. However, challenges such as the legalization of cannabis as an alternative and issues related to prescription drug abuse may hinder market growth.

Market Size of Global Opioids Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Opioids Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 23.94 Billion
Market Size (2029) USD 28.78 Billion
CAGR (2024 - 2029) 3.75 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Opioids Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Opioids Market Analysis

The Global Opioids Market size is estimated at USD 23.94 billion in 2024, and is expected to reach USD 28.78 billion by 2029, growing at a CAGR of 3.75% during the forecast period (2024-2029).

Globally, the COVID-19 pandemic showed many negative effects across the medical spectrum, which include a decrease in face-to-face appointments and an increase in telehealth visits. The COVID-19 pandemic also resulted in a period of isolation to maintain sufficient capacity in hospitals and to reduce the spread of the virus. Chronic pain was one of the hardest-hit fields from the COVID-19 pandemic, leaving many patients overburdened with their chronic pain and their ongoing treatment delayed. For instance, according to a research article by Rajendra K Sahoo et a., published in the Indian Journal of Anesthesia 2020, the study results found that 63.16% of pain physicians had a fear of spreading or contracting the disease to patients' family members, 26.79% had impaired sleep, 1.43% physicians were feeling depressed, and 8.14% had feelings of anxiety. Also, opioid use at high doses and for long periods of time can impair immune system function, complicating the course of COVID-19 disease. In various stages of the COVID-19, potential suppression of parts of the immune response may be important in prevention, clinical support, and therapeutic use of medications.

Some of the other major factors driving the market growth include the increasing prevalence of diseases that cause chronic pain, such as cancer, arthritis, lower back pain, fibromyalgia and postsurgical pain, inclination toward extended-release formulations from the immediate release of opioids, and the rising focus on the abuse-deterrent formulation (ADF) by generic manufacturers.

Opioids are considered as most effective drugs for the management of pain. Moreover, their use in the management of chronic pain is considered to be standard practice in most parts of the world. Due to an increase in the burden of medical ailments, the Opioids market is expected to grow over the forecast period.

Furthermore, opioids play a key role in post-operative settings to provide adequate analgesia. As per the Center for Disease Control and Prevention October 2021 estimates, about 1 in 4 United States adults (23.7%) or about 58.5 million people have doctor-diagnosed arthritis and this is expected to reach 78 million by 2045. Opioid therapy is the mainstay of orthopedic treatment of patients with moderate to severe pain, and this helps to drives the overall growth of the market. However, factors such as the advent and legalization of cannabis as an alternative to opioids and prescription drug abuse are expected to impede market growth over the forecast period.

Opioids Industry Segmentation

As per the scope of the report, opioids are a class of drugs that act on the nervous system to reduce pain. They are primarily used for pain relief and for anesthesia. The global opioids market is segmented by product type (codeine, fentanyl, morphine, meperidine, methadone, and other product types), receptor binding (strong agonist and mild to moderate agonist), application (pain management (cancer pain, neuropathic pain, osteoarthritis pain, and other pain management), cold and cough, diarrhea, and other applications), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Type
Codeine
Fentanyl
Morphine
Meperidine
Methadone
Other Product Types
By Receptor Binding
Strong Agonist
Mild to Moderate Agonist
By Application
Pain Management
Cancer Pain
Neuropathic Pain
Osteoarthritis Pain
Other Pain Managements
Cold and Cough
Diarrhoea
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Opioids Market Size Summary

The opioids market is poised for growth, driven by the increasing prevalence of chronic pain conditions such as cancer, arthritis, and postsurgical pain. Opioids remain a standard practice for pain management globally, particularly in post-operative settings where they provide essential analgesia. The market is also influenced by a shift towards extended-release formulations and a focus on abuse-deterrent formulations by generic manufacturers. Despite the challenges posed by the COVID-19 pandemic, which disrupted pain management services and highlighted the complexities of opioid use during health crises, the demand for opioids is expected to rise. The market's expansion is supported by strategic initiatives from key players, including product approvals and collaborations, aimed at enhancing their portfolios and market presence.

In North America, the opioids market is bolstered by the rising incidence of orthopedic diseases and chronic conditions, alongside a growing geriatric population and increased disposable income. However, the market faces challenges from the legalization of cannabis as an alternative to opioids and issues related to prescription drug abuse. The fragmented and competitive nature of the market sees numerous players, with larger companies dominating due to stringent regulatory policies that hinder smaller firms' market entry. Despite these challenges, the market is expected to experience significant growth, driven by the ongoing need for effective pain management solutions and the strategic efforts of major pharmaceutical companies.

Explore More

Global Opioids Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Prevalence of Orthopedic Diseases and Chronic Pain

      2. 1.2.2 Inclination toward Extended Release Formulations from Immediate Release of Opioids

      3. 1.2.3 Rising Focus on Abuse-deterrent Formulation (ADF) by Generic Manufacturers

    3. 1.3 Market Restraints

      1. 1.3.1 Advent and Legalization of Cannabis as an Alternative to Opioids

      2. 1.3.2 Prescription Drug Abuse

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product Type

      1. 2.1.1 Codeine

      2. 2.1.2 Fentanyl

      3. 2.1.3 Morphine

      4. 2.1.4 Meperidine

      5. 2.1.5 Methadone

      6. 2.1.6 Other Product Types

    2. 2.2 By Receptor Binding

      1. 2.2.1 Strong Agonist

      2. 2.2.2 Mild to Moderate Agonist

    3. 2.3 By Application

      1. 2.3.1 Pain Management

        1. 2.3.1.1 Cancer Pain

        2. 2.3.1.2 Neuropathic Pain

        3. 2.3.1.3 Osteoarthritis Pain

        4. 2.3.1.4 Other Pain Managements

      2. 2.3.2 Cold and Cough

      3. 2.3.3 Diarrhoea

      4. 2.3.4 Other Applications

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle-East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle-East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Opioids Market Size FAQs

The Global Opioids Market size is expected to reach USD 23.94 billion in 2024 and grow at a CAGR of 3.75% to reach USD 28.78 billion by 2029.

In 2024, the Global Opioids Market size is expected to reach USD 23.94 billion.

Opioids Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)